TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pharmore Consulting AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
307
|
227 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
65
|
41 | |
| EBITDA |
65
|
38 | |
| Total assets |
87
|
60 | |
| Current assets |
81
|
54 | |
| Current liabilities |
27
|
18 | |
| Equity capital |
60
|
42 | |
| - share capital |
9
|
9 | |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
69.0%
|
70.0% | |
| Turnover per employee |
154
|
114 | |
| Profit as a percentage of turnover |
21.2%
|
18.1% | |
| Return on assets (ROA) |
74.7%
|
68.3% | |
| Current ratio |
300%
|
300% | |
| Return on equity (ROE) |
108.3%
|
97.6% | |
| Change turnover |
79
|
35 | |
| Change turnover % |
4%
|
35%
|
18% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.